Outcome of two patient education methods on recruitment and compliance with ivermectin in the treatment of onchocerciasis

Patient Education and Counseling

Volumn 29, Issue 3, 1996, Pages 237-245

  Oladepo, Oladimeji ^a   Okunade, Adebimpe ^a   Brieger, William R ^a   Oshiname, Frederick O ^a   Ajuwon, Ademola J ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

compliance; ivermectin; onchocerciasis

Indexed keywords

IVERMECTIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; EDUCATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCHOCERCIASIS; PATIENT COMPLIANCE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANTINEMATODAL AGENTS; CHILD; FEMALE; HUMANS; IVERMECTIN; MALE; MIDDLE AGED; NIGERIA; ONCHOCERCIASIS; PATIENT COMPLIANCE; PATIENT DROPOUTS; PATIENT EDUCATION;

EID: 17044448979     PISSN: 07383991     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0738-3991(96)00916-0     Document Type: Article

References (26)

1. [1] Lucas AO. Sustaining treatment programs. In: Mectizan (ivermectin) and the control of onchocerciasis: strengthening the global impact. Summary proceedings of the symposium. Merck and Company Inc., 1992; 43.
2. [2] Oladepo O. The role of patient education in the treatment of onchocerciasis in a rural Nigeria community [PhD dissertation]. Ibadan: University of Ibadan, 1986.
3. [3] Rothova A et al. Side-effects of ivermectin in treatment of onchocerciasis. Lancet 1989; June 24: 1439-1441.
4. [4] Anderson J, Fuglsand H, Marshall TF. Effects of diethylcarbamazine on ocular onchocerciasis. Tropenmed Parasitol 1976; 26: 263-278.
5. [5] Aziz MA et al. Efficacy and tolerance of ivermectin in human onchocerciasis. Lancet 1982; July 42: 171-173.
6. [6] Bryceson ADM, Warrell DA, Pope HM. Dangerous reactions to treatment of onchocerciasis with diethylcarbamazine. Br Med J 1977; i: 742-44.
7. [7] Oladepo O, Brieger WR, Adeniyi JD, Kale OO. An educational diagnosis of the factors affecting compliance in the treatment of onchocerciasis. Patient Educ Couns 1987; 9: 111-12.
8. [8] Oladepo O, Adeniyi JD, Brieger WR, Ayeni O, Kale OO. Onchocerciasis: the potential of patient education in the control of a tropical disease. Patient Educ Couns 1989; 13: 103-116.
9. [9] Godal T. A research agenda for onchocerciasis. In: Mectizan (ivermectin) and the control of onchocerciasis: strengthening the global impact. Summary proceedings of the symposium. Merck and Company Inc., 1992; 47-48.
10. [10] Richard-Lenoble D et al. Ivermectin in loiasis and concomitant O. volvulus and M. perstans infections. Am J Trop Med Hyg 1988; 39 (5): 480-483.
11. [11] Green BM. Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis. N Engl J Med 1985; 313 (3): 133-138.
12. [12] Taylor HR. Facilitating treatment. In: Mectizan (ivermectin) and the control of onchocerciasis: strengthening the global impact. Summary proceedings of the symposium. Merck and Company Inc. 1992; 43-44.
13. [13] World Health Organization. Strategies for ivermectin distribution through primary health care systems. Geneva: World Health Organization Program for the Prevention of Blindness, 1991; WHO/PBL/91.21.
14. [14] Baraka OZ, Khier MM, Ahmed KM, Ali MMM, El Mardi AE, Mahmoud BM, Ali MH, Homeida MMA, Williams JF. Community based distribution of ivermectin in eastern Sudan: acceptability and early post-treatment reactions. Trans R Soc Trop Med Hyg 1995; 89: 316-318.
15. [15] Moyou Somo R, Ngosso A, Dinga JS, Enyong PA, Fobi G. A community-based trial of ivermectin for onchocerciasis control in the forest of southwestern Cameroon: clinical and parasitologic findings after three treatments. Am J Trop Med Hyg 1993; 48 (1): 9-13.
16. [16] Whitworth JAG, Morgan D, Maude GH, Luty AJF, Taylor DW. A community trial of ivermectin for onchocerciasis in Sierra Leone: clinical and parasitological responses to four doses given at 6-monthly intervals. Trans R Soc Trop Med Hyg 1992; 86: 277-280.
17. [17] Burnham G. Ivermectin treatment of onchocercal skin lesions: observations from a placebo-controlled, double-blind trial in Malawi. Am J Trop Med Hyg 1995; 51 (1).
18. [18] Gordis L. Why patients don't follow medicine advice. A study of children on long-term anti streptococcal prophylaxis. J Paediatr 1969; 75: 957-968.
19. [19] Pass MF, Levine DM. Design of an experimental intervention to increase family reinforcement in the home for patient compliance. Am J Public Health 1975; 65 (9).
20. [20] Omolewa M. Community development literacy and health project report. University of Ibadan, Nigeria, 1991.
21. [21] Oshinowo Y. Africare onchocerciasis news. Mectizan Program Notes 1992; 4: 6.
22. [22] Israel BA. Social networks and social support: implications for natural helper and community level interventions. Health Educ Q 1985; 12 (1): 65-80.
23. [23] Ngoumou P, Walsh JF. A manual for rapid epidemiological mapping of onchocerciasis. Geneva: World Health Organization, 1993; TDR/TDE/ONCHO/93.4.
24. [24] Ngoumou P, Essomba RO, Godin C. Ivermectin-based onchocerciasis control in Cameroon. World Health Forum 1996; 17 (1): 25-28.
25. [25] Brieger WR. Maternal migrations and child health. J Trop Pediatr 1984; 30: 262-264.
26. [26] Ososanya OO, Brieger WR. Rural-urban mobility in southwestern Nigeria: implications for HIV/AIDS transmission from urban to rural communities. Health Educ Res 1994; 9 (4): 507-518.